Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Depreciation & Amortization (CF) (2020 - 2024)

Historic Depreciation & Amortization (CF) for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to $86116.0.

  • Immuneering's Depreciation & Amortization (CF) fell 405.33% to $86116.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $355807.0, marking a year-over-year increase of 1021.98%. This contributed to the annual value of $355807.0 for FY2024, which is 1021.98% up from last year.
  • As of Q4 2024, Immuneering's Depreciation & Amortization (CF) stood at $86116.0, which was down 405.33% from $88949.0 recorded in Q3 2024.
  • Immuneering's Depreciation & Amortization (CF)'s 5-year high stood at $90533.0 during Q2 2024, with a 5-year trough of $5656.0 in Q3 2020.
  • Its 5-year average for Depreciation & Amortization (CF) is $52121.7, with a median of $68075.0 in 2022.
  • In the last 5 years, Immuneering's Depreciation & Amortization (CF) soared by 46833.36% in 2022 and then tumbled by 405.33% in 2024.
  • Over the past 5 years, Immuneering's Depreciation & Amortization (CF) (Quarter) stood at $7449.0 in 2020, then soared by 98.89% to $14815.0 in 2021, then surged by 418.81% to $76862.0 in 2022, then rose by 16.77% to $89754.0 in 2023, then dropped by 4.05% to $86116.0 in 2024.
  • Its Depreciation & Amortization (CF) was $86116.0 in Q4 2024, compared to $88949.0 in Q3 2024 and $90533.0 in Q2 2024.